Atika Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.37M Sell
19,125
-1,517
-7% -$340K 0.69% 47
2025
Q4
$4.4M Sell
20,642
-1,518
-7% -$314K 0.61% 60
2025
Q3
$4.41M Buy
22,160
+5,760
+35% +$1.07M 0.38% 64
2025
Q2
$2.83M Sell
16,400
-18,800
-53% -$3.06M 0.3% 54
2025
Q1
$5.49M Buy
+35,200
New +$5.03M 0.84% 41
2024
Q4
Sell
-43,000
Closed -$6.42M 91
2024
Q3
$6.42M Buy
+43,000
New +$5.81M 0.69% 49
2024
Q2
Sell
-48,500
Closed -$7.33M 93
2024
Q1
$7.33M Buy
+48,500
New +$6.92M 0.82% 52
2020
Q1
Sell
-52,000
Closed -$7.23M 88
2019
Q4
$7.23M Buy
52,000
+27,000
+108% +$3M 1.54% 32
2019
Q3
$2.41M Sell
25,000
-16,000
-39% -$1.78M 0.63% 58
2019
Q2
$4.72M Sell
41,000
-5,000
-11% -$598K 1.05% 47
2019
Q1
$5.41M Buy
+46,000
New +$4.03M 1.55% 40
2018
Q3
Sell
-15,700
Closed -$1.04M 88
2018
Q2
$1.04M Buy
+15,700
New +$1.03M 0.3% 83

Other funds holding ASND